Loren Data's SAM Daily™

fbodaily.com
Home Today's SAM Search Archives Numbered Notes CBD Archives Subscribe
FBO DAILY - FEDBIZOPPS ISSUE OF MARCH 24, 2018 FBO #5965
SOLICITATION NOTICE

68 -- Asante Rapid Recency Kits and Reader.

Notice Date
3/22/2018
 
Notice Type
Presolicitation
 
NAICS
325413 — In-Vitro Diagnostic Substance Manufacturing
 
Contracting Office
Department of Health and Human Services, Centers for Disease Control and Prevention, Procurement and Grants Office (Atlanta), 2920 Brandywine Road, Room 3000, Atlanta, Georgia, 30341-4146
 
ZIP Code
30341-4146
 
Solicitation Number
0000HCWG-2018-19809
 
Archive Date
4/21/2018
 
Point of Contact
Linda F. Williams, Phone: 770-488-2692
 
E-Mail Address
luw9@cdc.gov
(luw9@cdc.gov)
 
Small Business Set-Aside
N/A
 
Description
Department of Health and Human Services, Centers for Disease Control and Prevention, Office of Financial Resources, Office of Acquisition Services, Room 3000, 2920 Brandywine Road, Atlanta, GA 30341-3724 The Centers for Disease Control and Prevention (CDC), Center for Global Health (CGH) Division of Global HIV & Tuberculosis (DGHT), Global TB Prevention and Control Branch, intends to negotiate a sole source contract with Sedia Biosciences Corporation for Asante Rapid Recency Kits and Asante Strip Reader for field implementation of rapid recency test in Rwanda. Sedia Biosciences Corporation is the only manufacturer of the Asante Rapid Recency Kits and Reader. The justification for this non-competitive action is in accordance with 13.106-1(b)(1), only one source is reasonably available which states that, "For purchases not exceeding the simplified acquisition threshold. (i) Contracting officers may solicit from one source if the contracting officer determines that the circumstances of the contract action deem only one source reasonably available. This notice of intent is not a request for competitive proposals. A determination to compete this procurement based on a response to this notice is solely within the discretion of the Government. Interested parties who believe they possess the capabilities to satisfy this requirement should submit a Capability Statement demonstrating their abilities to meet this requirement. All responses will be considered. All Capability Statements shall be received by the closing date of this synopsis and shall be submitted in writing. Responses may be sent via email to luw9@cdc.gov. No solicitation will be issued. No telephone inquiries will be accepted.
 
Web Link
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/CDCP/PGOA/0000HCWG-2018-19809/listing.html)
 
Place of Performance
Address: Centers for Disease Control and Prevention, Atlanta, Georgia, 30341, United States
Zip Code: 30341
 
Record
SN04863222-W 20180324/180322230949-3f41ea69e479aa62b068f1724ceeacca (fbodaily.com)
 
Source
FedBizOpps Link to This Notice
(may not be valid after Archive Date)

FSG Index  |  This Issue's Index  |  Today's FBO Daily Index Page |
ECGrid: EDI VAN Interconnect ECGridOS: EDI Web Services Interconnect API Government Data Publications CBDDisk Subscribers
 Privacy Policy  Jenny in Wanderland!  © 1994-2024, Loren Data Corp.